Abstract
Summary
Administration of antilymphocyte serum (ALS) resulted in augmentation of “takes,” growth, and metastases of transplanted mouse mammary tumors in their syngeneic C3HeB/FeJ hosts.
Get full access to this article
View all access options for this article.